jueves, 12 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 9, 2026

The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8%

View original at nasdaq.com
The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8% The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Experts estimate it would take tens of billions of dollars of investment and many years to meaningfully ramp up oil production in Venezuela

    80% confidence
  • 5 Hidden Yield dividend stocks are poised to deliver 15% annualized returns - enough to double investment every 5 years

    80% confidence
  • More than 10,000 rare diseases exist today but only 5% have approved medicines

    80% confidence
  • Verizon is falling short of its potential and needs to improve loyalty, retention, and operational efficiency

    80% confidence
  • Uncertain economic environment with mixed indicators - some like GDP and PCE are strong, but housing pressure and consumer uncertainty are impacting home improvement

    80% confidence
  • GLP-1 drugs can't put a dent in Coca-Cola despite worries from bears

    80% confidence
  • Keytruda won't start to lose exclusivity until late 2028

    80% confidence
  • U.S. housing market is begging for investment - industry has been underbuilding for years and nearly three-quarters of existing homes are 25 years old or greater

    80% confidence
  • Dogs of the Dow strategy works because it is contrarian - high yields for blue chips signal value as these stocks are out of favor, not going out of business

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,565 documentos fuente archivados
Consulta estos datos → isubstrate.com
The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8% — Source | Via News | es.VIA.NEWS